Page last updated: 2024-08-23

etoposide and Carcinoma, Neuroendocrine

etoposide has been researched along with Carcinoma, Neuroendocrine in 131 studies

Research

Studies (131)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (3.05)	18.2507
2000's	20 (15.27)	29.6817
2010's	76 (58.02)	24.3611
2020's	31 (23.66)	2.80

Authors

Authors	Studies
Economidou, SC; Fotopoulos, G; Vrontis, K	1
Fukushima, M; Otaki, T; Usui, Y	1
Abdel-Rahman, O; Koski, SL	1
Chen, J; Feng, ST; Li, Z; Luo, Y; Shi, S; Song, C; Wang, Y	1
Endo, S; Fujiwara, Y; Higashida, M; Iwamoto, R; Katada, Y; Kinoshita, S; Kitagawa, S; Kubota, H; Mineta, S; Okada, T; Sanuki, F; Tanaka, H; Ueno, M; Ueno, T; Yoshimatsu, K	1
Chen, Y; Han, B; Hu, M; Qian, F; Wang, Y; Yang, Z; Zhang, W; Zhang, Y	1
Alabi, BR; Liu, S; Stoyanova, T	1
Baudin, E; Beaulaton, C; Blanchet, O; Chatelain, D; Do Cao, C; Ducreux, M; Faron, M; Hadoux, J; Hautefeuille, V; Hervieu, V; Hescot, S; Joubert Zakeyh, J; Kanaan, C; Laboureau, S; Leteurtre, E; Lombard-Bohas, C; Marchal, A; Perrier, M; Petorin, C; Rousselet, MC; Scoazec, JY; Tauveron, I; Walter, T	1
Boku, N; Furuse, J; Hiraoka, N; Honma, Y; Ikeda, M; Kataoka, T; Kato, K; Kitagawa, Y; Machida, N; Mizuno, N; Morizane, C; Nomura, S; Okano, N; Okusaka, T; Ozaka, M; Sato, T; Sekine, S; Taniguchi, H; Terashima, M; Ueno, M; Yamaguchi, K	1
Fukuhara, M; Matsumura, Y; Mine, H; Muto, S; Okabe, N; Ozaki, Y; Shio, Y; Suzuki, H; Takagi, H; Watanabe, M; Yamaguchi, H	1
Adamo, V; Cantale, O; Castorina, L; Chillari, F; Colarossi, C; Esposito, F; Franchina, T; Giuffrida, D; Puliafito, I; Ricciardi, GRR; Russo, A; Sciacca, D; Vitale, MP	1
Kim, KD; Lee, KY; Shin, WY	1
Kimura, T; Kurita, T; Miyoshi, AI; Ueda, Y; Yoshino, K	1
Al Tamimi, NS; Belbaraka, R; Bennouna, Y; El Fadli, M	1
Emi, M; Hamai, Y; Hirano, K; Hirohata, R; Ohsawa, M; Okada, M; Yamaguchi, S; Yoshikawa, T	1
Chaturvedi, P; Chaukar, DA; Ghosh Laskar, S; Kumar Singh, A; Menon, N; Noronha, V; Pai, PS; Patil, VM; Patlekar, G; Prabhash, K; Saha, S; Yadav, N	1
Bhosale, P; Chisholm, GB; Flores Legarreta, A; Frumovitz, M; Gonzales, NR; Jhingran, A; Ramalingam, P; Saab, R; Salvo, G	1
Chargari, C; Escande, A; Espenel, S; Morcet-Delattre, R; Tas, P	1
Griswold, D; Nakamoto, K; Sanabria, J; Weaver, A	1
Buckner, J; Duma, N; Halfdanarson, T; Reed, CT	1
Abbas, HA; An, T; Chang, L; Chen, H; Chen, R; Chen, W; Dong, Z; Futreal, PA; Glisson, BS; Gong, Y; Guan, Y; Heymach, JV; Hong, L; Kalhor, N; Lee, JJ; Lewis, J; Li, J; Li, Z; Rinsurongkawong, W; Roarty, EB; Roth, JA; Swisher, SG; Wang, J; Wang, Y; Wang, Z; Wistuba, II; Wu, M; Wu, N; Xia, X; Yang, L; Yang, X; Yi, X; Zhang, J; Zhao, J; Zhong, J; Zhu, X; Zhuo, M	1
Boku, N; Daiko, H; Hirano, H; Honma, Y; Inaba, K; Itami, J; Ito, Y; Iwasa, S; Kanamori, J; Kato, K; Murakami, N; Nagashima, K; Oguma, J; Okita, N; Shoji, H; Takashima, A	1
Han, Y; Li, L; Sun, H	1
Chorath, J; Gong, J; Guan, M; Hendifar, A; Kamrava, M; Klempner, SJ; Nassir, Y; Nissen, N; Placencio-Hickok, VR	1
Huang, M; Jiang, L; Qin, Y; Yu, M; Zhou, L	1
Li, J; Lu, M; Peng, Z; Shen, L; Wang, X; Zhang, P; Zhang, X; Zhou, J	1
Cai, LH; Chen, JP; Fu, WH; Hao, HK; He, QL; Huang, CM; Jiang, LX; Li, E; Li, HL; Li, P; Li, SL; Li, Y; Li, YX; Li, Z; Lin, JP; Lin, JX; Lin, W; Tian, YT; Xie, JW; Xu, YC; Xu, ZK; Xue, FQ; Zhao, G; Zhao, YJ; Zheng, CH; Zhou, XJ; Zhou, YB; Zhu, ZG; Zou, BB	1
Di Sabatino, A; Furlan, D; La Rosa, S; Martino, M; Neri, G; Perfetti, V; Sessa, F; Solcia, E; Vanoli, A; Viglio, A	1
Endo, M; Fukuda, K; Hasegawa, N; Hattori, J; Hirose, S; Hyodo, I; Ishige, K; Kawai, H; Komatsu, Y; Mizokami, Y; Mizui, T; Nagase, M; Sato, M; Yamamoto, Y; Yamaura, M	1
Afchain, P; Baudin, E; Desgrippes, R; Hadoux, J; Hautefeuille, V; Lepage, C; Lorgis, V; Monterymard, C; Scoazec, JY; Thuillier, F; Tougeron, D; Walter, T	1
Azzopardi, N; Babic, D; Delicata, NP; Montebello, A; Zahra Bianco, E	1
Baudin, E; Beaulaton, C; Blanchet, O; Cadiot, G; Chatelain, D; Do Cao, C; Ducreux, M; Durand, A; Faron, M; Gu, C; Hadoux, J; Hautefeuille, V; Hervieu, V; Hescot, S; Jannin, A; Kanaan, C; Laboureau, S; Leteurtre, E; Marchal, A; Petorin, C; Rousselet, MC; Scoazec, JY; Tauveron, I; Walter, T; Zakeyh, JJ	1
Asa, SL; Dorth, J; Mohamed, A; Prantesh, J	1
Chang, KM; Chang, SJ; Chen, TC; Chen, YT; Chuang, YJ; Lai, ZY; Yeo, HY	1
Aparicio, T; Baudin, E; Bonnet, I; Cadiot, G; Coriat, R; Dahan, L; Desauw, C; Guimbaud, R; Hentic, O; Le Malicot, K; Lecomte, T; Legoux, JL; Lepage, C; Lepère, C; Lombard-Bohas, C; Malka, D; Manfredi, S; Roquin, G; Scoazec, JY; Thirot-Bidault, A; Tougeron, D; Walter, T	1
Allinson, K; Candy, N; Carr, O; McMillen, J; Trivedi, R; Young, A	1
Damhuis, RA; den Bakker, MA; Derks, JL; Dingemans, AC; Groen, HJ; Smit, EF; Speel, EM; Thunnissen, E; van den Broek, EC; van Suylen, RJ	1
Barbera, MA; Biasco, G; Bondi, A; Brandi, G; Brighi, N; Campana, D; Corbelli, J; Pantaleo, MA; Paragona, M	1
Cheng, YM; Chiang, CT; Chou, CY; Huang, YF; New, GH; Tsai, HW; Wu, PY	1
Cheng, Y; He, T; Pei, X; Wu, X; Xiang, L; Yang, H; Yang, W; Ye, S	1
Hope, AJ; Papp, S; Perez-Ordóñez, B; Wasserman, JK	1
Fujita, M; Hashimoto, D; Inaba, Y; Ninomiya, R	1
Goel, M; Kanetkar, AV; Khobragade, KH; Ostwal, V; Patkar, S; Ramaswamy, A	1
Chen, CA; Chen, YL; Cheng, WF; Lin, MC; Tu, YA	1
Moeller, M; Schuette, W; Siebolts, U; Wickenhauser, C	1
Beck, Y; Komagome, M; Maki, A; Mitsui, T; Miyata, Y; Nakazawa, A; Ninomiya, R; Ozawa, F	1
Filipiak, KJ; Kowalik, R; Płatek, AE; Szymanski, FM	1
Cheng, WH; Ho, CH; Lee, WH; Tzou, KY	1
Horimatsu, T; Mishima, M; Miyamoto, S	1
Hata, K; Hidaka, T; Iwasaki, Y; Matsuhashi, A; Okuzumi, S; Shimizu, S; Takahashi, H	1
Barriuso, J; Frizziero, M; Hubner, RA; Lamarca, A; McNamara, MG; Valle, JW	1
Hattori, H; Inagaki, H; Murakami, S; Nakamura, Y; Nakayama, M; Ozaki, S; Suzuki, M; Yokota, M	1
Hamano, Y; Hyodo, I; Moriwaki, T; Sakashita, S; To, K; Watahiki, T; Yamada, T	1
Boudreaux, JP; Ramirez, RA; Thiagarajan, R; Thomas, KEH; Voros, BA; Woltering, EA	1
Arai, H; Honda, M; Kobayashi, Y; Yasuhara, Y; Yoshida, K	1
Barriuso, J; Fazio, N; Frizziero, M; Hubner, RA; Kordatou, Z; Lamarca, A; Manoharan, P; Mansoor, W; McNamara, MG; Nuttall, C; Spada, F; Valle, JW	1
Hwang, J; Kim, DW; Lee, EJ	1
Bergstrom, C; Fang, Y; Porembka, J; Sarode, V; Syed, S	1
Berard, H; Boffa, S; Chouaid, C; Damotte, D; Le Caer, H; Le Treut, J; Lena, H; Monnet, I; Sault, MC; Souquet, PJ; Vergnenegre, A	1
Boutzios, G; Chatzellis, E; Kaltsas, G; Koumarianou, A; Tsavaris, N	1
Chi, YH; Du, F; Jiang, WC; Song, Y; Sun, YK; Wang, JW; Yang, L; Zhou, AP	1
Brasch, F; Gehl, HB; Görner, M; Hirnle, P; Scholtz, LU; Sudhoff, H; Wegehenkel, K	1
Angarita, FA; Meek, E; Rodríguez, JL; Sánchez, JO; Tawil, M; Torregrosa, L	1
Al-Jiffry, BO; Al-Malki, O	1
Duque, M; Gupta, A; Saif, MW	1
Hosokawa, S; Mineta, H; Okamura, J; Takizawa, Y	1
Fetterly, GJ; Fong, MK; Iyer, RV; McDougald, LJ	1
Asamura, H; Eba, J; Katayama, H; Kenmotsu, H; Niho, S; Shibata, T; Tamura, T; Tsuboi, M; Watanabe, S; Yamamoto, N	1
Pantongrag-Brown, L; Pittayanon, R; Rerknimitr, R; Wisedopas, N	1
Bellefqih, S; Benjaafar, N; Kebdani, T; Khalil, J; Mezouri, I	1
Daoud, J; Elloumi, F; Fourati, N; Frikha, M; Ghorbel, A; Ghorbell, L; Jlidi, R; Siala, W	1
Liu, SX; Wang, HY; Yan, JQ; Zhou, GY; Zou, J	1
Boku, N; Furuse, J; Ishido, K; Kasuga, A; Machida, N; Morizane, C; Nishina, T; Okusaka, T; Sudo, K; Takahashi, H; Tobimatsu, K; Yamaguchi, T	1
Ayala, AG; Choi, EK; Divatia, M; Miles, BJ; Okoye, E; Ro, JY	1
Costa, DB; Desai, NV; Folch, E; Gangadharan, SP; Huberman, MS; Karp, RS; Kent, MS; Le, X; Majid, A; Rangachari, D; VanderLaan, PA	1
Ikeda, M; Kondo, S; Mitsunaga, S; Morizane, C; Ohno, I; Okusaka, T; Okuyama, H; Shimizu, S; Takahashi, H; Ueno, H	1
Fang, J; Liu, LF; Wu, MJ; Yin, ZM; Yu, AJ; Yu, H; Zhu, JQ	1
Hassan, U; Mozayani, B; Wong, NA	1
Chang, GJ; Crane, CH; Das, P; Feig, BW; Krishnan, S; Minsky, BD; Rashid, A; Skibber, JM; Voong, KR; Wolff, RA; Yao, JC	1
Imai, H; Ishioka, C; Komine, K; Okita, A; Saijo, K; Shimodaira, H; Shirota, H; Takahashi, M; Takahashi, S	1
Beddok, A; Faraldi, M; Ngatchou Taenga, ÉC; Rakotonavalona, A; Vanbocksteal, J	1
Ameratunga, M; du Plessis, J; Gan, H; Lee, WI	1
Chang, DK; Cho, YB; Ha, SY; Hong, SN; Huh, JW; Kim, HC; Kim, ST; Kim, YH; Lee, J; Lee, WY; Park, YA; Park, YS; Yun, SH	1
Algren, SD; Dziadek, OL; Ruiz, MP	1
Wolin, EM	1
Fazio, N; Milione, M	1
Jeong, HY; Kang, SH; Kim, DK; Kim, MH; Moon, HS; Seong, JK	1
Antona, AD; Cipolla, C; Ciulla, A; Graceffa, G; Grillo, A; Locurto, P; Martorana, S; Vieni, S	1
Adamenko, O; Belfiori, G; Cardinali, L; Crippa, S; Doglioni, C; Falconi, M; Muffatti, F; Palucci, M; Partelli, S; Zamboni, G	1
Hosoda, Y; Imamura, M; Kawai, J; Kiyochi, H; Komoto, I; Nishiyama, K; Ogura, N; Okabe, A; Oshima, Y; Sugimoto, T; Taki, Y; Tsunekawa, S	1
Gress, TM; Rinke, A	1
Abu-Rustum, NR; Aghajanian, C; Alektiar, K; Chi, DS; Diaz, JP; Konner, J; Leitao, MM; Park, KJ; Zhao, H; Zivanovic, O	1
Chan, MY; Leung, CW; Li, WW; Pong, WM; Yau, TN	1
Hiroshima, K; Iwadate, Y; Iyoda, A; Moriya, Y; Nakatani, Y; Takiguchi, Y; Uno, T; Yoshino, I	1
Baldi, GG; Cupini, S; Falcone, A; Fornaro, L; Loupakis, F; Masi, G; Salvatore, L; Stasi, I; Vasile, E	1
Hagihara, A; Hiraoka, N; Ikeda, M; Iwasa, S; Kojima, Y; Kondo, S; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Tanaka, T; Ueno, H	1
Araki, M; Hasegawa, H; Ikura, Y; Itoh, M; Kuzushita, N; Mita, E; Nakazuru, S; Ohta, M; Suemura, S; Toyama, T; Yoshio, T; Yoshioka, C	1
Cassier, P; Chapet, O; Chekrine, T; De Bari, B; Kulisa, M; Mornex, F	1
Busch, C; Knappskog, S; Oberg, K; Sebjornsen, S; Sorbye, H; Welin, S	1
Assens, M; Federspiel, B; Hansen, CP; Hasselby, JP; Jepsen, I; Kjaer, A; Knigge, U; Langer, SW; Olsen, IH	1
Akiyama, S; Gamoh, M; Narasaka, T; Niitani, T; Ohto, T	1
Isowa, N; Izumi, H; Miura, H; Sakaguchi, Y; Shimizu, E; Takeda, K; Tokuyasu, H	1
Han, GS; Wang, JB; Zhang, YC; Zhuang, J	1
Borca, VC; Cante, D; Canzi, P; Carassai, P; Catuzzo, P; Ceroni, P; Franco, P; Girelli, G; La Porta, MR; Migliaccio, F; Numico, G; Ozzello, F; Pasquino, M; Ricardi, U; Sciacero, P; Tofani, S	1
Hai-Yan, S; Jian-Qing, Z; Lan-Fang, L; Ya-Qing, C; Zuo-Ming, Y	1
Berlin, J; Black, J; E Engel, M; Fagan, EL; Shoemaker, AH; Slone, JS	1
Abedallaa, N; Baey, C; Besse, B; de Montpreville, VT; Fabre, D; Guigay, J; Pechoux, CL; Pignon, JP; Planchard, D; Soria, JC; Tremblay, L	1
Couvelard, A; Gillet, A; Goujon, G; Hammel, P; Hentic, O; Lévy, P; Maire, F; Palazzo, M; Rebours, V; Ruszniewski, P; Zappa, M	1
Chen, W; He, Y; Peng, J; Song, W; Zhang, S	1
Chen, J; Huang, XY; Tang, J; Yang, Z; Yuan, Z; Zheng, Q	1
Aiello, E; Colarossi, C; Costanzo, R; Giuffrida, D; Martinetti, D; Memeo, L; Pino, P	1
Hosoya, Y; Kaneko, Y; Koinuma, K; Nagai, H; Saito, K; Yasuda, Y	1
Antoniozzi, A; Assenza, M; Caramanico, L; De Angelis, G; Mingoli, A; Modini, C; Romagnoli, F; Tomei, B	1
Frank, R; Kelly, WK; Reuter, V; Scher, HI; Schwartz, L; Steineck, G	1
Al, A; Baykal, C; Bulbul, D; Güler, G; Küçükali, T; Ozer, S; Tulunay, G	1
Asamura, H; Kodama, T; Kunitoh, H; Matsuno, Y; Ohe, Y; Saijo, N; Sekine, I; Takei, H; Tamura, T; Tsuchiya, R; Yamamoto, N; Yamazaki, S	1
De Braud, F; Di Meglio, G; Fazio, N; Grana, C; Lorizzo, K; Pelosi, G; Torrisi, R; Tradati, N	1
Greco, FA; Hainsworth, JD; Litchy, S; Spigel, DR	1
Fujisawa, T; Hiroshima, K; Iizasa, T; Iyoda, A; Kimura, H; Moriya, Y; Nakatani, Y; Sekine, Y; Shibuya, K; Takiguchi, Y	1
Casali, C; Morandi, U	1
Arroyo, SV; Palacios, E; Rosel, P	1
Horn, A; Sørbye, H; Westre, B	1
Fujiwara, Y; Kunitoh, H; Nokihara, H; Ohe, Y; Sekine, I; Tamura, T; Tsuta, K; Yamada, K; Yamamoto, N	1
Balta, Z; Büttner, R; Fischer, HP; Hirner, A; Sauerbruch, T	1
Anderson, D; Leonetti, JP; Marzo, S; Shirazi, MA	1
Amrein, PC; Bhattacharyya, N; Goodman, ML; Joseph, MP; Thornton, AF	1
Fujikawa, K; Hoshii, Y; Ishizu, K; Kawamura, H; Konishi, M; Naito, K; Ohmi, C; Shimizu, Y; Takahashi, M; Yamaguchi, S	1
Billy, C; Carette, MF; Ferroir, JP; Milleron, B; Nahum, L; Ropert, A; Tcherakian, S	1
Arai, E; Horii, Y; Iwamura, H	1
Boruta, DM; Castrillon, DH; Crum, CP; Duska, LA; Schorge, JO; Sheets, EE	1
Eriksson, BK; Eriksson, C; Fjällskog, ML; Granberg, DP; Janson, ET; Oberg, KE; Welin, SL	1

Reviews

27 review(s) available for etoposide and Carcinoma, Neuroendocrine

Article	Year
Current and emerging therapies for neuroendocrine prostate cancer. Pharmacology & therapeutics, 2022, Volume: 238 Topics: Carcinoma, Neuroendocrine; Etoposide; Humans; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Taxoids	2022
Mixed Primary Hepatocellular Carcinoma and Hepatic Neuroendocrine Carcinoma: Case Report and Literature Review. Medicina (Kaunas, Lithuania), 2023, Feb-20, Volume: 59, Issue:2 Topics: Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local	2023
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix. Anticancer research, 2023, Volume: 43, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cervix Uteri; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Platinum; Rare Diseases; Small Cell Lung Carcinoma; Uterine Cervical Neoplasms	2023
Metastatic Small Cell Carcinoma of a Male Breast: A Case Report and Review of the Literature. The Gulf journal of oncology, 2023, Volume: 1, Issue:42 Topics: Breast Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Etoposide; Humans; Male; Middle Aged; Prognosis	2023
Role of radiotherapy in the management of rare gynaecological cancers. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2023, Volume: 27, Issue:8 Topics: Brachytherapy; Carcinoma, Neuroendocrine; Etoposide; Female; Humans; Retrospective Studies; Uterine Cervical Neoplasms	2023
Nasopharyngeal neuroendocrine neoplasms: Systematic review of the literature and case presentation. Journal of neuroendocrinology, 2021, Volume: 33, Issue:8 Topics: Adult; Anemia, Sickle Cell; Antineoplastic Agents; Black or African American; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Magnetic Resonance Imaging; Male; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography	2021
Large cell neuroendocrine carcinoma of the endometrium: A case report and literature review. Taiwanese journal of obstetrics & gynecology, 2018, Volume: 57, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Endometrial Neoplasms; Endometrium; Etoposide; Female; Humans; Middle Aged; Salvage Therapy	2018
Sinonasal inverted papilloma associated with small cell neuroendocrine carcinoma: A case report and literature review of rare malignancies associated with inverted papilloma. Auris, nasus, larynx, 2019, Volume: 46, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Maxillary Sinus Neoplasms; Nasal Obstruction; Nasal Polyps; Nose Neoplasms; Otorhinolaryngologic Surgical Procedures; Papilloma, Inverted; Radiotherapy, Intensity-Modulated	2019
Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma. The oncologist, 2019, Volume: 24, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Intestinal Neoplasms; Irinotecan; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Stomach Neoplasms	2019
[PRIMARY SMALL CELL NEUROENDOCRINE CARCINOMA OF THE URETER]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2018, Volume: 109, Issue:1 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Combined Modality Therapy; Etoposide; Gastrectomy; Humans; Laparoscopy; Male; Neoplasms, Multiple Primary; Nephroureterectomy; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ureteral Neoplasms; Urologic Surgical Procedures, Male	2018
Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas. Endokrynologia Polska, 2013, Volume: 64, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Colonic Neoplasms; Diagnosis, Differential; Diagnostic Imaging; Etoposide; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Platinum Compounds; Prognosis; Receptors, Somatostatin; Retrospective Studies; Small Cell Lung Carcinoma	2013
Neuroendocrine small cell rectal cancer metastasizing to the liver: a unique treatment strategy, case report, and review of the literature. World journal of surgical oncology, 2013, Jul-11, Volume: 11 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Rectal Neoplasms; Review Literature as Topic; Somatostatin; Tomography, X-Ray Computed	2013
Treatment of poorly differentiated neuroendocrine carcinoma of the pancreas. JOP : Journal of the pancreas, 2013, Jul-10, Volume: 14, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Humans; Paclitaxel; Pancreatic Neoplasms; Receptor, IGF Type 1; TOR Serine-Threonine Kinases; Treatment Outcome	2013
[Small cell neuroendocrine carcinoma of the uterine cervix: Report of six cases and a review of the literature]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:3 Topics: Adult; Antineoplastic Agents; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Metastasis; Radiotherapy, Adjuvant; Retrospective Studies; Uterine Cervical Neoplasms	2014
Primary small cell neuroendocrine carcinoma of the tonsil: a case report and review of the literature. International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Immunohistochemistry; Male; Middle Aged; Mitotic Index; Neoplasm Recurrence, Local; Time Factors; Tomography, X-Ray Computed; Tonsillar Neoplasms; Treatment Outcome; Tumor Burden	2014
De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature. International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Cystoscopy; Disease Progression; Etoposide; Fatal Outcome; Humans; Immunohistochemistry; Laparoscopy; Leuprolide; Lymph Node Excision; Lymphatic Metastasis; Male; Meningeal Neoplasms; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Paclitaxel; Pelvis; Prostatic Neoplasms; Robotic Surgical Procedures; Time Factors; Tomography, X-Ray Computed; Transurethral Resection of Prostate; Treatment Outcome	2014
Chemotherapy for advanced poorly differentiated pancreatic neuroendocrine carcinoma. Journal of hepato-biliary-pancreatic sciences, 2015, Volume: 22, Issue:8 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Neuroendocrine; Cisplatin; Drug Administration Schedule; Etoposide; Everolimus; Humans; Irinotecan; Pancreatic Neoplasms	2015
Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung. Chest, 2017, Volume: 151, Issue:5 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Carcinoma, Neuroendocrine; Cisplatin; Disease Management; Etoposide; Everolimus; Humans; Lung Neoplasms; Neuroendocrine Tumors; Octreotide; Peptides, Cyclic; Pneumonectomy; Small Cell Lung Carcinoma; Somatostatin	2017
Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications. Cancer treatment reviews, 2016, Volume: 50 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cell Proliferation; Etoposide; Humans; Intestinal Neoplasms; Intestine, Small; Ki-67 Antigen; Neoplasm Grading; Pancreatic Neoplasms; Platinum Compounds; Prognosis; Stomach Neoplasms	2016
Primary neuroendocrine carcinoma of the breast A single Center experience and review of the literature. Annali italiani di chirurgia, 2016, Nov-28, Volume: 87 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Estrogens; Etoposide; Female; Humans; Mastectomy; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Progesterone; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Receptors, Steroid; Retrospective Studies; Sentinel Lymph Node Biopsy; Tamoxifen	2016
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology. World journal of gastroenterology, 2016, Dec-07, Volume: 22, Issue:45 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Proliferation; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Ki-67 Antigen; Mitotic Index; Neoadjuvant Therapy; Neoplasm Staging; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Prognosis	2016
Neuroendocrine Cancer, Therapeutic Strategies in G3 Cancers. Digestion, 2017, Volume: 95, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Gastrointestinal Neoplasms; Humans; Irinotecan; Ki-67 Antigen; Neoplasm Grading; Neuroendocrine Tumors; Practice Guidelines as Topic; Prognosis; Treatment Outcome	2017
[Case of primary hepatic neuroendocrine carcinoma diagnosed by needle biopsy]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2010, Volume: 107, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Neuroendocrine; Carcinoma, Transitional Cell; Cisplatin; Diagnosis, Differential; Diagnostic Imaging; Etoposide; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Urinary Bladder Neoplasms	2010
[Small cell neuroendocrine carcinoma of the bladder: A case report and review of the literature]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2011, Volume: 15, Issue:3 Topics: Acute Kidney Injury; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma in Situ; Carcinoma, Neuroendocrine; Carcinoma, Transitional Cell; Combined Modality Therapy; Emergencies; Etoposide; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Prognosis; Prostatic Hyperplasia; Topoisomerase I Inhibitors; Topotecan; Urinary Bladder Neoplasms	2011
[Combined treatment with CDDP and radiation effective against neuroendocrine carcinoma of the urinary bladder: a case report]. Hinyokika kiyo. Acta urologica Japonica, 1999, Volume: 45, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Treatment Outcome; Urinary Bladder Neoplasms	1999
[Small cell neuroendocrine carcinoma of the urinary bladder: a case report]. Hinyokika kiyo. Acta urologica Japonica, 1999, Volume: 45, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Etoposide; Humans; Lymphatic Metastasis; Male; Middle Aged; Urinary Bladder Neoplasms	1999
Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Gynecologic oncology, 2001, Volume: 81, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Uterine Cervical Neoplasms; Vincristine	2001

Trials

9 trial(s) available for etoposide and Carcinoma, Neuroendocrine

Article	Year
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical Trial. JAMA oncology, 2022, 10-01, Volume: 8, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Digestive System; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged	2022
Etoposide and cisplatin versus irinotecan and cisplatin as the first-line therapy for patients with advanced, poorly differentiated gastroenteropancreatic neuroendocrine carcinoma: A randomized phase 2 study. Cancer, 2020, 05-01, Volume: 126 Suppl 9 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Irinotecan; Lung Neoplasms	2020
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2021, Volume: 53, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Neuroendocrine; Etoposide; Female; Fluorouracil; Humans; Intestinal Neoplasms; Irinotecan; Leucovorin; Male; Neoplasm Metastasis; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Oxaliplatin; Pancreatic Neoplasms; Platinum Compounds; Progression-Free Survival; Prospective Studies; Quality of Life; Stomach Neoplasms; Survival Rate; Treatment Outcome	2021
Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies	2013
A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206). Japanese journal of clinical oncology, 2014, Volume: 44, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Clinical Protocols; Disease-Free Survival; Etoposide; Female; Humans; Incidence; Irinotecan; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Patient Selection; Survival Analysis; Treatment Outcome	2014
Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system. Cancer science, 2014, Volume: 105, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Fluorouracil; Gastrointestinal Neoplasms; Gemcitabine; Humans; Irinotecan; Kaplan-Meier Estimate; Leucovorin; Male; Organoplatinum Compounds; Oxaliplatin; Prognosis; Proportional Hazards Models; Retrospective Studies; Treatment Outcome	2014
Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Aug-01, Volume: 24, Issue:22 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Prospective Studies; Survival Analysis; Treatment Outcome	2006
Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma. The Annals of thoracic surgery, 2006, Volume: 82, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Prospective Studies; Survival Analysis; Treatment Outcome	2006
Treatment with cisplatin and etoposide in patients with neuroendocrine tumors. Cancer, 2001, Sep-01, Volume: 92, Issue:5 Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Survival Analysis	2001

Other Studies

95 other study(ies) available for etoposide and Carcinoma, Neuroendocrine

Article	Year
Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience. Cancer investigation, 2022, Volume: 40, Issue:2 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Prospective Studies; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome	2022
[A Case of Primary Neuroendocrine Carcinoma of the Retroperitoneum]. Hinyokika kiyo. Acta urologica Japonica, 2021, Volume: 67, Issue:9 Topics: Aged, 80 and over; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Humans; Male; Retroperitoneal Neoplasms; Tomography, X-Ray Computed	2021
Cisplatin-Based versus Carboplatin-Based Chemotherapy for Extrapulmonary Neuroendocrine Carcinomas: A Real-World Study. Neuroendocrinology, 2022, Volume: 112, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Lung Neoplasms; Platinum	2022
Optimization of the tumour response threshold in advanced gastroenteropancreatic neuroendocrine carcinomas treated with cisplatin/etoposide combined chemotherapy. European journal of radiology, 2022, Volume: 147 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Neuroendocrine Tumors; Treatment Outcome	2022
[A Case of Pancreas Neuroendocrine Carcinoma Achieved Long-Term Survival by Carboplatin plus Etoposide Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2021, Volume: 48, Issue:13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Fluorouracil; Humans; Male; Pancreas; Pancreatic Neoplasms	2021
Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2022, 07-11, Volume: 62, Issue:2 Topics: Adenocarcinoma; Adult; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Etoposide; Female; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Retrospective Studies	2022
Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC study. Endocrine-related cancer, 2022, 10-01, Volume: 29, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Platinum; Prognosis; Retrospective Studies	2022
Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report. Thoracic cancer, 2022, Volume: 13, Issue:19 Topics: Aged; Anaplastic Lymphoma Kinase; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; ErbB Receptors; Etoposide; Humans; Immune Checkpoint Inhibitors; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local	2022
Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis. Frontiers in endocrinology, 2023, Volume: 14 Topics: Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Lung; Lung Neoplasms; Neuroendocrine Tumors; Platinum; Retrospective Studies	2023
Esophageal Neuroendocrine Carcinoma With Pathological Complete Response After Neoadjuvant Chemotherapy Followed by Robot-assisted Surgery: A Case Report. Anticancer research, 2023, Volume: 43, Issue:7 Topics: Aged; Carboplatin; Carcinoma, Neuroendocrine; Esophageal Neoplasms; Etoposide; Female; Humans; Neoadjuvant Therapy; Robotic Surgical Procedures	2023
Real world data on long term outcome of neoadjuvant chemotherapy in locally advanced esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation - Results from a single centre study. Oral oncology, 2023, Volume: 144 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Esthesioneuroblastoma, Olfactory; Etoposide; Humans; Middle Aged; Nasal Cavity; Neoadjuvant Therapy; Nose Neoplasms; Paranasal Sinus Neoplasms; Retrospective Studies; Young Adult	2023
Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2023, 09-04, Volume: 33, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Prognosis; Registries; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult	2023
Large-Cell Neuroendocrine Carcinoma of the Gallbladder: A Rare Case. The American surgeon, 2019, Jul-01, Volume: 85, Issue:7 Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Gallbladder Neoplasms; Humans; Mastectomy, Segmental; Radiotherapy; Treatment Outcome	2019
Primary neuroendocrine carcinoma of the brain. BMJ case reports, 2019, Sep-18, Volume: 12, Issue:9 Topics: Adult; Antineoplastic Agents; Carcinoma, Neuroendocrine; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Ventriculoperitoneal Shunt	2019
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 02-15, Volume: 26, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cell-Free Nucleic Acids; Deoxycytidine; Etoposide; Female; Gemcitabine; Genomics; High-Throughput Nucleotide Sequencing; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Organoplatinum Compounds; Pemetrexed; Prognosis; Survival Rate; Taxoids	2020
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy. Cancer medicine, 2020, Volume: 9, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate	2020
Computed Tomography and Magnetic Resonance Imaging in the Diagnosis of Primary Neuroendocrine Tumors of the Liver. World neurosurgery, 2020, Volume: 138 Topics: Ablation Techniques; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Chemoembolization, Therapeutic; Cisplatin; Etoposide; Female; Hepatectomy; Humans; Liver Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Neuroendocrine Tumors; Octreotide; Tomography, X-Ray Computed	2020
Durable Response to Carboplatin, Etoposide, Nivolumab, and Ipilimumab in Metastatic High-Grade Neuroendocrine Carcinoma of the Gallbladder. Pancreas, 2020, Volume: 49, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Female; Gallbladder; Humans; Ipilimumab; Ki-67 Antigen; Middle Aged; Mutation; Neoplasm Grading; Neoplasm Metastasis; Nivolumab; Retinoblastoma Binding Proteins; Treatment Outcome; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases	2020
Durable response to combination radiotherapy and immunotherapy in EP-resistant lung large-cell neuroendocrine carcinoma with Immunotherapy, 2020, Volume: 12, Issue:4 Topics: AMP-Activated Protein Kinase Kinases; beta 2-Microglobulin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemoradiotherapy; Drug Resistance, Neoplasm; Etoposide; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Ipilimumab; Lung Neoplasms; Male; Middle Aged; Mutation; Nivolumab; Protein Serine-Threonine Kinases; Radiosurgery; Treatment Outcome	2020
Adjuvant chemotherapy for patients with gastric neuroendocrine carcinomas or mixed adenoneuroendocrine carcinomas. The British journal of surgery, 2020, Volume: 107, Issue:9 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Propensity Score; Stomach Neoplasms; Survival Analysis	2020
Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient Pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift. Endocrine pathology, 2020, Volume: 31, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; DNA Mismatch Repair; Etoposide; Humans; Male; Microsatellite Instability; Middle Aged; Mismatch Repair Endonuclease PMS2; MutL Protein Homolog 1; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Pancreaticoduodenectomy; Remission Induction	2020
Mediastinal Neuroendocrine Carcinoma Slowly Growing for 8 Years after Surgical Resection of Esophageal Squamous Cell Carcinoma. Internal medicine (Tokyo, Japan), 2020, Oct-15, Volume: 59, Issue:20 Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Etoposide; Female; Humans; Lymph Nodes; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy; Treatment Outcome	2020
Large cell neuroendocrine carcinoma arising from the anterior mediastinum. BMJ case reports, 2021, May-25, Volume: 14, Issue:5 Topics: Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Etoposide; Female; Humans; Mediastinum; Middle Aged; Prognosis	2021
Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the E European journal of cancer (Oxford, England : 1990), 2021, Volume: 152 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Immunohistochemistry; Male; Middle Aged; Prognosis; Progression-Free Survival; Retinoblastoma Binding Proteins; Retrospective Studies; Risk Assessment; Ubiquitin-Protein Ligases; Young Adult	2021
PI3K inhibitor enhances the cytotoxic response to etoposide and cisplatin in a newly established neuroendocrine cervical carcinoma cell line. Oncotarget, 2017, Jul-11, Volume: 8, Issue:28 Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Carcinoma, Neuroendocrine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Disease Models, Animal; DNA Damage; Drug Synergism; Etoposide; Female; Humans; Mice; Papillomavirus Infections; Phosphoinositide-3 Kinase Inhibitors; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays	2017
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort. European journal of cancer (Oxford, England : 1990), 2017, Volume: 79 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Transformation, Neoplastic; Cisplatin; Cohort Studies; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis	2017
Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath. World neurosurgery, 2017, Volume: 104 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Etoposide; Female; Femoral Nerve; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Nerve Sheath Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2017
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter? The European respiratory journal, 2017, Volume: 49, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Docetaxel; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Netherlands; Paclitaxel; Pemetrexed; Registries; Small Cell Lung Carcinoma; Taxoids; Vinblastine; Vinorelbine	2017
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms. Journal of chemotherapy (Florence, Italy), 2018, Volume: 30, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Retrospective Studies; Stomach Neoplasms	2018
Case report: term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix. BMC women's health, 2017, 07-28, Volume: 17, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Fertility; Humans; Ifosfamide; Neoplasm Staging; Pregnancy; Term Birth; Uterine Cervical Neoplasms	2017
Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix. Gynecologic oncology, 2017, Volume: 147, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Neoplasm Staging; Retrospective Studies; Uterine Cervical Neoplasms	2017
Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of a Case with Complete Clinical and Radiological Response After Combined Chemoradiotherapy. Head and neck pathology, 2018, Volume: 12, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Epstein-Barr Virus Infections; Etoposide; Humans; Male; Nasopharyngeal Neoplasms; Tuberous Sclerosis	2018
[Conversion Therapy Using Etoposide and Cisplatin Chemotherapy for Liver Metastases from Advanced Gastric Mixed Adenoneuroendocrine Carcinoma - A Case Report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms	2017
Neuroendocrine Carcinoma of Gallbladder: A Step Beyond Palliative Therapy, Experience of 25 Cases. Journal of gastrointestinal cancer, 2019, Volume: 50, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cholecystectomy; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Gallbladder Neoplasms; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Treatment Outcome	2019
[Non-Small Cell Lung Cancer - Development of Parallel Mechanisms of Resistance]. Pneumologie (Stuttgart, Germany), 2018, Volume: 72, Issue:7 Topics: Acrylamides; Aniline Compounds; Antineoplastic Agents; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Etoposide; Humans; Lung Neoplasms; Mutation; Piperazines; Protein Kinase Inhibitors; Treatment Outcome	2018
[Conversion Surgery after Etoposide/Cisplatin(EP)Therapy for Huge Pancreatic Neuroendocrine Carcinoma - A Case Report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Pancreatic Neoplasms	2018
Giant small-cell neuroendocrine carcinoma infiltrating the heart. Kardiologia polska, 2018, Volume: 76, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Male; Mediastinal Neoplasms; Middle Aged	2018
Primary large cell neuroendocrine carcinoma of the prostate in a hormone naive patient: A case report from Taiwan. Journal of cancer research and therapeutics, 2018, Volume: 14, Issue:Supplement Topics: Aged; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Male; Prostate; Prostatic Neoplasms; Taiwan; Transurethral Resection of Prostate	2018
Acute Respiratory Failure During Systemic Chemotherapy. Gastroenterology, 2019, Volume: 156, Issue:4 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cecal Neoplasms; Cisplatin; Etoposide; Fatal Outcome; Female; Humans; Irinotecan; Middle Aged; Neoplastic Cells, Circulating; Respiratory Insufficiency; Thrombotic Microangiopathies	2019
Large Cell Neuroendocrine Carcinoma of the Mediastinum Successfully Treated with Systemic Chemotherapy after Palliative Radiotherapy. Internal medicine (Tokyo, Japan), 2019, Feb-15, Volume: 58, Issue:4 Topics: Aged; Antineoplastic Agents; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Mediastinum; Treatment Outcome	2019
Urgent need for consensus: international survey of clinical practice exploring use of platinum-etoposide chemotherapy for advanced extra-pulmonary high grade neuroendocrine carcinoma (EP-G3-NEC). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2019, Volume: 21, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Follow-Up Studies; Humans; Lung Neoplasms; Needs Assessment; Neoplasm Grading; Practice Guidelines as Topic; Practice Patterns, Physicians'	2019
A Neuroendocrine Tumor of Unknown Primary Origin that Responded to Treatment Based on Tumor Grade Progression. Internal medicine (Tokyo, Japan), 2019, Apr-15, Volume: 58, Issue:8 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Hormones; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Somatostatin; Treatment Outcome	2019
Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas. Neuroendocrinology, 2019, Volume: 109, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Differentiation; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neuroendocrine Tumors; Retrospective Studies; Treatment Outcome; Young Adult	2019
Small-cell neuroendocrine carcinoma of the uterine cervix with pancreatic metastasis: a case report and a review of the literature. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2019, Volume: 39, Issue:4 Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Neoplasm Invasiveness; Palliative Care; Pancreatic Neoplasms; Uterine Cervical Neoplasms; Whole Body Imaging	2019
Primary neuroendocrine carcinoma of the breast. The breast journal, 2019, Volume: 25, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Neuroendocrine; Cisplatin; Contrast Media; Etoposide; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Ultrasonography, Mammary	2019
[Neuroendocrine tumors: analysis of 252 cases]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2013, Volume: 35, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoid Tumor; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Cisplatin; Digestive System Neoplasms; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Palliative Care; Retrospective Studies; Sex Factors; Survival Rate; Young Adult	2013
Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas--a single institution experience. European journal of cancer care, 2013, Volume: 22, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome	2013
Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature. World journal of surgical oncology, 2013, Jun-05, Volume: 11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Female; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Review Literature as Topic	2013
Long-term survival of a patient with primary small cell neuroendocrine carcinoma of the maxillary sinus: a case report. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2013, Volume: 71, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Humans; Induction Chemotherapy; Male; Maxillary Sinus Neoplasms; Middle Aged	2013
Carboplatin pharmacokinetics in a patient receiving hemodialysis. Pharmacotherapy, 2014, Volume: 34, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Humans; Kidney Failure, Chronic; Male; Renal Dialysis	2014
Asymptomatic primary rectal neuroendocrine carcinoma presented as a large pelvic mass. BMJ case reports, 2014, Feb-03, Volume: 2014 Topics: Antineoplastic Combined Chemotherapy Protocols; Asymptomatic Diseases; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Humans; Incidental Findings; Lymphatic Metastasis; Male; Middle Aged; Rectal Neoplasms; Tomography, X-Ray Computed	2014
[Large cell neuroendocrine carcinoma of the nasopharynx: A case report]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:3 Topics: Adult; Antineoplastic Agents; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Fatal Outcome; Humans; Male; Meningeal Neoplasms; Nasal Obstruction; Nasopharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Tinnitus	2014
De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors. Lung cancer (Amsterdam, Netherlands), 2015, Volume: 88, Issue:1 Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Neuroendocrine; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Etoposide; Fatal Outcome; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Radiography; Small Cell Lung Carcinoma	2015
Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma. European journal of gynaecological oncology, 2015, Volume: 36, Issue:3 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Hepatic Insufficiency; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine	2015
Primary combined neuroendocrine carcinoma (small-cell type) and squamous cell carcinoma of the colon. Histopathology, 2016, Volume: 68, Issue:5 Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Colon; Colonic Neoplasms; Etoposide; Fatal Outcome; Humans; Male; Platinum; Point Mutation; Proto-Oncogene Proteins p21(ras); Tomography, X-Ray Computed	2016
Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal. American journal of clinical oncology, 2017, Volume: 40, Issue:6 Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Capecitabine; Carboplatin; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Consolidation Chemotherapy; Diarrhea; Digestive System Surgical Procedures; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Induction Chemotherapy; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Pelvis; Radiation Injuries; Radiodermatitis; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Rectum; Retrospective Studies; Survival Rate; Tumor Burden	2017
Efficacy and Safety of Carboplatin and Etoposide Combination Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma: A Retrospective Case Series. Chemotherapy, 2016, Volume: 61, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Disease-Free Survival; Etoposide; Female; Humans; Male; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome	2016
[Small cell neuroendocrine carcinoma of the upper urinary tract: A case report]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2016, Volume: 20, Issue:1 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Humans; Lymphatic Metastasis; Male; Radiotherapy, Adjuvant; Remission Induction; Ureteral Neoplasms	2016
Hypopharyngeal large cell neuroendocrine carcinoma. BMJ case reports, 2015, Dec-29, Volume: 2015 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Endoscopy, Gastrointestinal; Etoposide; Fatal Outcome; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngoscopy; Male; Middle Aged; Treatment Outcome	2015
The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution. Medicine, 2016, Volume: 95, Issue:19 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Colorectal Neoplasms; Disease-Free Survival; Endoscopy, Digestive System; Etoposide; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult	2016
Nonsurgical Management of Neuroendocrine Cancer of the Cervix: Brief Report. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2016, Volume: 26, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Middle Aged; Missouri; Retrospective Studies; Uterine Cervical Neoplasms	2016
A Case of Endoscopically Complete Remission of Esophageal Neuroendocrine Tumors by Concurrent Chemoradiation Therapy. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2016, Nov-25, Volume: 68, Issue:5 Topics: Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Chemoradiotherapy; Chromogranin A; Cisplatin; Esophageal Neoplasms; Esophagoscopy; Etoposide; Female; Humans; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Synaptophysin	2016
[Recurrent Gastric Carcinoma(Endocrine Cell Type)Successfully Treated with Multidisciplinary Therapy - A Case Report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Female; Gastrectomy; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Recurrence; Stomach Neoplasms	2016
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy. Gynecologic oncology, 2009, Volume: 112, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms	2009
Large-cell neuroendocrine carcinoma of the uterine cervix complicating pregnancy. Hong Kong medical journal = Xianggang yi xue za zhi, 2009, Volume: 15, Issue:1 Topics: Abortion, Induced; Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cervix Uteri; Etoposide; Female; Humans; Polyps; Pregnancy; Pregnancy Complications, Neoplastic; Treatment Outcome; Uterine Cervical Neoplasms	2009
Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma. The Journal of thoracic and cardiovascular surgery, 2009, Volume: 138, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis	2009
Refractory neuroendocrine tumor-response to liposomal doxorubicin and capecitabine. Nature reviews. Clinical oncology, 2009, Volume: 6, Issue:11 Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Neuroendocrine; Cisplatin; Deoxycytidine; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Octreotide; Radiography; Treatment Outcome	2009
Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas. Japanese journal of clinical oncology, 2010, Volume: 40, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Carcinoma, Neuroendocrine; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Retrospective Studies	2010
Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy. Cancer, 2011, Oct-15, Volume: 117, Issue:20 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Capecitabine; Carcinoma, Neuroendocrine; Cisplatin; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Promoter Regions, Genetic; Retrospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins	2011
First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience. Acta oncologica (Stockholm, Sweden), 2012, Volume: 51, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Survival Rate; Treatment Outcome; Vincristine	2012
[Poorly-differentiated neuroendocrine carcinoma of ascending colon with liver metastases successfully treated with carboplatin and etoposide]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Differentiation; Colonic Neoplasms; Combined Modality Therapy; Etoposide; Female; Humans; Liver Neoplasms	2011
Large cell neuroendocrine carcinoma arising from the left main bronchus. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:18 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Bronchoscopy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasm Staging; Tomography, X-Ray Computed; Treatment Outcome	2011
[Diagnosis, treatment and prognosis of neuroendocrine carcinoma of the colorectum]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2011, Volume: 14, Issue:12 Topics: Carcinoma, Neuroendocrine; Cisplatin; Colorectal Neoplasms; Etoposide; Female; Humans; Male; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate	2011
Head and neck region consolidation radiotherapy and prophylactic cranial irradiation with hippocampal avoidance delivered with helical tomotherapy after induction chemotherapy for non-sinonasal neuroendocrine carcinoma of the upper airways. Radiation oncology (London, England), 2012, Feb-15, Volume: 7 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cisplatin; Cranial Irradiation; Etoposide; Head and Neck Neoplasms; Hippocampus; Humans; Induction Chemotherapy; Male; Middle Aged; Organ Sparing Treatments; Remission Induction; Respiratory Tract Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2012
Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases. European journal of gynaecological oncology, 2012, Volume: 33, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Neuroendocrine; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Time Factors; Uterine Cervical Neoplasms	2012
Neuroendocrine carcinoma in an adolescent with hypercortisolemia. Journal of pediatric hematology/oncology, 2012, Volume: 34, Issue:3 Topics: Adolescent; Adrenalectomy; Adrenocortical Hyperfunction; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Combined Modality Therapy; Etoposide; Humans; Male; Neoadjuvant Therapy; Tomography, X-Ray Computed	2012
Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymph Nodes; Male; Methotrexate; Middle Aged; Neoplasm Staging; Perioperative Care; Platinum; Pneumonectomy; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate	2012
FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3. Endocrine-related cancer, 2012, Volume: 19, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Carcinoma, Neuroendocrine; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Pancreatic Neoplasms; Pelvic Neoplasms; Platinum; Treatment Outcome	2012
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy. Diagnostic pathology, 2012, Nov-27, Volume: 7 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carboplatin; Carcinoma, Neuroendocrine; Cystectomy; Etoposide; Female; Gallbladder Neoplasms; Hepatectomy; Humans; Immunohistochemistry; Liver Neoplasms; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Neoplasms, Complex and Mixed; Octreotide; Paclitaxel; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2012
Neuroendocrine carcinoma of the pancreas with soft tissue metastasis. World journal of gastroenterology, 2012, Dec-07, Volume: 18, Issue:45 Topics: Adult; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Laparotomy; Male; Neoplasm Metastasis; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Phosphopyruvate Hydratase; Positron-Emission Tomography; Soft Tissue Neoplasms; Splenectomy; Tomography, X-Ray Computed; Treatment Outcome	2012
Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder: a case report. Diagnostic pathology, 2013, Feb-04, Volume: 8 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Etoposide; Fatal Outcome; Female; Humans; Immunohistochemistry; Middle Aged; Neoadjuvant Therapy; Treatment Outcome; Urinary Bladder Neoplasms	2013
A case of aggressive neuroendocrine carcinoma of the stomach. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2003, Volume: 6, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Male; Middle Aged; Omentum; Pancreatic Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms; Tomography, X-Ray Computed	2003
[Digestive hemorrhage from a duodenal neuroendocrine tumor. Diagnostic-therapeutic features and emergency surgical strategy]. Il Giornale di chirurgia, 2003, Volume: 24, Issue:3 Topics: Abdomen, Acute; Adolescent; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Duodenal Diseases; Duodenal Neoplasms; Emergencies; Etoposide; Gastrointestinal Hemorrhage; Humans; Intestinal Perforation; Male; Shock, Hemorrhagic	2003
Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements. Acta oncologica (Stockholm, Sweden), 2002, Volume: 41, Issue:7-8 Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Estramustine; Etoposide; Humans; Male; Middle Aged; Prostatic Neoplasms; Remission Induction	2002
High-grade neuroendocrine carcinoma of the cervix. A case report. Gynecologic and obstetric investigation, 2005, Volume: 59, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Female; Gynecologic Surgical Procedures; Humans; Neoplasm Staging; Radiotherapy, Adjuvant; Treatment Outcome; Uterine Cervical Neoplasms	2005
Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy. Lung cancer (Amsterdam, Netherlands), 2005, Volume: 49, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Treatment Outcome; Vindesine	2005
Successful chemotherapy and 90Y-DOTATOC in a patient with mediastinal highly aggressive neuroendocrine carcinoma. Acta oncologica (Stockholm, Sweden), 2006, Volume: 45, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Disease Progression; Etoposide; Female; Humans; Mediastinal Neoplasms; Middle Aged; Neoplasms, Unknown Primary; Octreotide; Remission Induction; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2006
Invited commentary. The Annals of thoracic surgery, 2006, Volume: 82, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Lung Neoplasms; Pneumonectomy; Survival Analysis	2006
Poorly differentiated neuroendocrine tumor of the larynx: challenging and highly aggressive. Ear, nose, & throat journal, 2006, Volume: 85, Issue:11 Topics: Adult; Antineoplastic Agents; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Fatal Outcome; Female; Headache; Hoarseness; Humans; Laryngeal Neoplasms; Laryngoscopy; Lethargy; Magnetic Resonance Imaging; Radiotherapy, Adjuvant; Tomography, X-Ray Computed	2006
Curative surgery after neoadjuvant chemotherapy in metastatic poorly differentiated neuroendocrine carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2007, Volume: 33, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Pancreas; Remission Induction; Tomography, X-Ray Computed	2007
Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung. Japanese journal of clinical oncology, 2007, Volume: 37, Issue:7 Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Docetaxel; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Retrospective Studies; Taxoids; Vinblastine; Vinorelbine	2007
[Primary neuroendocrine carcinoma of the liver. From carcinoid tumor to small-cell hepatic carcinoma: case reports and review of the literature]. Der Pathologe, 2008, Volume: 29, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoid Tumor; Carcinoma; Carcinoma, Neuroendocrine; Cell Differentiation; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Rectal Neoplasms; Risk Factors; Treatment Outcome	2008
Neuroendocrine carcinoma of the jugular foramen. Ear, nose, & throat journal, 2008, Volume: 87, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Ataxia; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Diagnosis, Differential; Etoposide; Female; Headache; Hearing Loss, Sensorineural; Humans; Jugular Veins; Magnetic Resonance Imaging; Middle Aged; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Skull Base Neoplasms; Tinnitus; Vertigo	2008
Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Results in 9 cases. Archives of otolaryngology--head & neck surgery, 1997, Volume: 123, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paranasal Sinus Neoplasms; Prospective Studies; Radiotherapy Dosage; Survival Analysis; Treatment Outcome	1997
[Atypical paraneoplastic myasthenic syndrome: Lambert-Eaton syndrome or myasthenia?]. Revue de pneumologie clinique, 1999, Volume: 55, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Lung; Lung Neoplasms; Middle Aged; Myasthenia Gravis; Paraneoplastic Syndromes; Radiotherapy Dosage; Tomography, X-Ray Computed	1999